The primary goal of our study is to develop metrics for screening the proteolytic stability and dimerization propensity of insulin based on MD simulations of monomers and their glycosylated analogs. The use of monomer simulations obviates the need of performing advanced sampling of more complicated systems, such as a protease-substrate complex or an insulin dimer. We also evaluated whether these metrics were independent of the initial configuration used.